David Lareau, CEO of Medicomp Systems, says this delay will mean ongoing challenges in access to accurate, complete data—which is more important now than ever before.
Due to the stress the pandemic has placed on health systems and hospitals, the Department of Health and Human Services’ (HHS) recently recommended delaying the implemented timelines for its long-awaited information blocking rule issued earlier this year in March.
This is the second time the Trump Administration has planned to delay the compliance deadlines for healthcare information blocking and interoperability regulations due to COVID-19.
The HHS sent the Office of Management and Budget (OMB) an interim final rule September 17 that revises the timelines.
HHS' information blocking rule requires that electronic health data be made available to patients at no cost and defines exceptions to data blocking. It was issued by both the Department of Health and Human Services' Office of the National Coordinator for Health Information Technology (ONC) and the Centers for Medicare & Medicaid Services (CMS).
The interim final rule implies the agency will extend dates identified in the information blocking provisions, including the November compliance deadline for providers as well as dates for the Conditions and Maintenance of Certification provisions requiring electronic health record (EHR) platforms to be interoperable.
The information blocking requirements were set to take effect November 2.
Although the delays make sense for those who are burdened, David Lareau, CEO of Medicomp Systems, says this delay will mean ongoing challenges in access to accurate, complete data—which is more important now than ever before.
Lareau says the impact of the delays will include:
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More